| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_174cc6580ecabdee169564cd446cbdbb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-621 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 |
| filingDate |
1999-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d60056109e1614a3dc29dfc4ae9483c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a82093bdfc0200517e836ae8323dcc5 |
| publicationDate |
1999-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0947198-A1 |
| titleOfInvention |
Pharmaceutical preparation containing folic acid and acetylsalicylic acid |
| abstract |
The invention relates to a pharmaceutical preparationnthat is suitable for oral administration, for the treatmentnand prophylaxis of cardiovascular disorders, comprisingnfolic acid and acetylsalicylic acid, or pharmaceuticallynacceptable salts or esters, or metabolites thereof, asnactive constituents and a pharmaceutically acceptablenexcipient. At least one of the active constituents isnpreferably provided separately with a coating. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6733781-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11166966-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2002230589-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0245571-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0245571-A3 |
| priorityDate |
1998-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |